Event Calendar
Prev MonthPrev Month Next MonthNext Month
2022-11 NCRAF Round Table
The Friday Conference Center
100 Friday Center Dr.
Chapel Hill, NC 27599
USA

View additional information
Wednesday, November 16, 2022, 5:30 PM - 8:00 PM EDT
Category: Events

The Roundtable Dinner is Back!

Wednesday Nov. 16 at the Friday Conference Center, Chapel Hill

Map and Directions: https://fridaycenter.unc.edu/map-and-directions/

Registration is Open!

As in years past, our Roundtable Dinner will feature a networking reception with complimentary bar and hors d'oeuvre, followed by buffet dinner with seating at multiple tables, each with a different speaker and discussion topic. Each table will be a unique opportunity to learn about a topic of your choosing with a local expert in the topic, in a small-group setting (6-10 persons/table).

5:30 to 6:30 pm Networking

6:30 to 8:00 pm  Dinner and Discussion

Table # Speaker & bio Topic & Description
1

Clare Matti, Associate Director, Regulatory Affairs, The FlexPro Group

EU Clinical Trial Regulation

A profound change was finally realized in January 2022 when the European Union’s Clinical Trial Regulation (CTR) entered into application with the “go live” of the Clinical Trials Information System (CTIS). (more...)

2 Brendan Baggot

Accelerating medical device regulatory approvals with clinical trial site operations.

3

Cynthia Nolte, Senior Director, ICON, plc.

Notified Body interactions during the review of technical documentation remediated to MDR and IVDR

4

Charles Jagun, Regulatory Senior Manager, Merz Aesthetics

Regulatory Intelligence – Medical Devices

 As product designs, development, and manufacturing change get more innovative, regulatory authorities have also become proactive and alert to guarantee medical device safety and effectiveness. (more...)

5

Shilpa Gampa, Delivery Manager, Medical Devices and IVD's Division, Freyr Inc

FDA medical device regulations and Submissions 

 

6

Cheng Li; Senior Principal Engineer at Aerie Pharmaceuticals

Combination Product Design Controls/QbD—Does it apply to you?

Do you work in the pharmaceutical or biotech industry? Do you or your organization play a key role in new or sustaining combination product development projects?  (more...)

7
Drusilla Scott, PhD, RAC, VP Regulatory Affairs,

Sobi, Inc.

Manna from Heaven - PDUFA VII

 

 

8 Nanditha Tula

Drug Approval Process for generic products, and GDUFA program

 

 

9 Amy Mihalchik 

Toxicology FAQs 

 

 

10

Kirsten Messmer, PhD, RAC, Senior Research Analyst, Agency IQ

Advanced Therapies – Lessons learned from regulatory challenges

 Advanced therapies are one of the fastest growth sectors in the biopharmaceutical industry. Several factors contribute or pose unique challenges for the development of these highly innovative products including: (more...)

11

Mike Lance, Senior Regulatory Affairs Associate, CMC & Labeling; United Therapeutics Corporation

Premarket Safety Analysis with FDA Medical Queries (FMQs)

Industry professionals often rely on medical queries to characterize adverse events for premarket safety assessment and for postmarket surveillance.  In the premarket setting, investigators utilize Preferred Terms and the over-arching Standardized MedDRA Queries (SMQ) to (more...)

12

Demetrius Carter, Certara Synchrogenix

Making the Switch: Transitioning your career into Regulatory Writing

Are you at a career crossroads? Have you ever considered Regulatory Writing? Very few people enter the field on a direct path but (more...)

13

Marissa Berry, Senior Manager of Regulatory Strategy, Hyloris Pharmaceuticals

The Logistics of Starting Your Own LLC/Consulting Company

 In this discussion, we will talk about the steps necessary for starting an LLC in North Carolina, the potential benefits of filing your LLC as an S corporation, and some of the pros and cons (more...)

14

Devin Rosenthal, VP NovaQuest Capital Management

Regulatory Affairs Influence in Investment Decision-making

Some may think of regulatory affairs as just a box-checking requirement or a paperwork-heavy burden, but did you know that it’s also foundational for the multimillion-dollar financings that fuel biopharma companies? (more...)

15

Kevin B Johnson, Chief Regulatory Officer, Ring Therapeutics

Storytelling, Hypnosis, and Vulcan Mind Melds:  The Art and Science of Persuasion in Regulatory Interactions

Influence and persuasion are key skills for successful interactions and negotiations with regulatory authorities. While extensively data-driven, regulatory documents are inherently persuasive in objective and function. (more...)


*****************************************************************************************************

Contact: [email protected]